Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huijuan Pu
Observed name:
H. Pu
Institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
Observed institutions:
Xuzhou Medical College,
Third Affiliated Hospital of Harbin Medical University,
Affiliated Hospital of Xuzhou Medical College
ORCID:
0009-0007-9197-4482
Observed ORCID:
0009-0007-9197-4482
OpenAlex ID:
A5069721773
Identification of risk factors for myocardial injury in acute ischemic stroke with diabetes mellitus: a retrospective cohort study on stroke-heart syndrome
2025
·
Huijuan Pu
, Yumin Wang
, et al.
·
Frontiers in Stroke
·
3
PDF
The inflammation burden index can predict the cardiac injury following antitumour therapy in lung cancer patients with diabetes
2025
·
Yumin Wang
, Chunyan Huan
, et al.
·
Scientific Reports
·
3
PDF
The Combined Prognostic Value of the Systemic Immune-Inflammation Index and LDL-C in Patients with AMI Undergoing PPCI
2025
·
Xiuli Zhang
, Ailin Liu
, et al.
·
Journal of Inflammation Research
·
2
PDF
A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients
2025
·
Yumin Wang
, Chunyan Huan
, et al.
·
Cardio-Oncology
·
1
The association between the C-reactive protein-triglyceride glucose index and myocardial injury after acute ischemic stroke: a machine learning analysis of the brain-heart axis
2026
·
Huijuan Pu
, Guoping Zhao
, et al.
·
Frontiers in Cardiovascular Medicine
PDF
Association Between Albumin‐Corrected Anion Gap and Mortality in ICU Patients With Acute Heart Failure: A MIMIC‐IV Cohort Study
2026
·
Huijuan Pu
, Guoping Zhao
, et al.
·
Cardiovascular Therapeutics
521P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II, single-arm, exploratory research
2023
·
Y. Zhao
, J. Liu
, et al.
·
Annals of Oncology
PDF
104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research
2022
·
Y. Zhao
, X. Wang
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
8
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type